Challenges and Opportunities with Contemporary GDMT in NYHA Class II/III HFrEF

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Challenges and Opportunities with Contemporary GDMT in NYHA Class II/III HFrEF

By CVRx | Barostim FEATURING William Abraham

0 views

July 31, 2024

Dr. Abraham discusses the challenges and opportunities with contemporary GDMT, Barostim's mechanism of action, and the post-market BeAT-HF trial results.

Comments 0

Real-World Experience with Baroreflex Activation Therapy: On-the-Job…

Feat. P. Mccann